REG - Surgical Innovations - Acquisition, PDMR Dealings and Directorate Changes <Origin Href="QuoteRef">SUNU.L</Origin>
RNS Number : 7036MSurgical Innovations Group PLC01 August 2017THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Surgical Innovations Group plc
("SI" or the "Company")
Completion of Acquisition, Director/PDMR dealings and Directorate changes
Further to the announcements on 27 July 2017, SI is pleased to announce that, following admission to trading on AIM of the 245,833,333 New Ordinary Shares today, the acquisition of Elemental Healthcare Limited has now completed.
Following the completion of the Acquisition, Adam Power and David Marsh have been appointed to the Board in the roles of Group Development Director and Group Commercial Director, respectively.
The information required under Schedule 2(g) of the AIM Rules in relation to the appointments is set out in Appendix I below.
The Company also announces that, following Admission, the subscriptions for New Ordinary Shares by certain existing Directors, as announced on 27 July 2017, have now completed. Further information on these transactions is set out in Appendix II below. The current shareholdings of each of the Directors who participated in the Fundraising and including the market purchases announced on 28 July 2017 are set out below:
Director
Holding of
Ordinary Shares
% of Enlarged
Share Capital
Nigel Rogers
4,803,863
0.62
Melanie Ross
1,573,710
0.20
Paul Hardy
6,730,185
0.86
Mike McMahon
18,504,737
2.37
Following Admission and the issue of the New Ordinary Shares, there are now 780,264,588 Ordinary Shares in issue.
Capitalised terms used but not defined in this announcement shall have the meanings defined in the announcement of the Acquisition, Vendor Placing and Subscriptions on 27 July 2017.
Contact details:
Surgical Innovations Group Plc
Nigel Rogers, Executive Chairman
Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)
Tel: 020 7220 1666
Tim Feather (Corporate Finance)
James Sinclair-Ford
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus
Mob: 07980 541893
Lianne Cawthorne
Mob: 07584 391303
APPENDIX I
Adam Power, aged 53, is a director of Elemental Healthcare Limited.
Following Admission, Adam Power, together with his wife, Alison Power, holds 27,812,500 Ordinary Shares, representing 3.56% of the enlarged share capital. In addition, Adam Power and Alison Power are interested in 3,437,500 Ordinary Shares, representing 0.44% of the enlarged share capital, as trustees of the Power Discretionary Trust.
David John Marsh, aged 52, is a director of Elemental Healthcare Limited and, within the last five years, was also a director of Alesi Surgical Limited.
Following Admission, David Marsh, together with his wife, Mary-Jane Marsh, holds 31,250,000 Ordinary Shares, representing 4.01% of the enlarged share capital.
In addition, Adam Power and David Marsh hold 1,000,000 options to acquire Ordinary Shares. The options were issued in January 2013 and are exercisable between January 2018 and January 2023 at a price of 6.88p per Ordinary Share.
There are no further disclosures required under Schedule 2(g) of the AIM Rules
APPENDIX II
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Nigel Rogers
2
Reason for the notification
a)
Position/status
Executive Chairman, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3p
710,385
d)
Aggregated information
- Aggregated volume
- Price
710,385
21,311.55
e)
Date of the transaction
1 August 2017
f)
Place of the transaction
London Stock Exchange, AIM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Melanie Ross
2
Reason for the notification
a)
Position/status
COO & CFO, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3p
333,333
d)
Aggregated information
- Aggregated volume
- Price
333,333
9,999.99
e)
Date of the transaction
1 August 2017
f)
Place of the transaction
London Stock Exchange, AIM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Paul Hardy
2
Reason for the notification
a)
Position/status
Non-Executive Director, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3p
1,538,990
d)
Aggregated information
- Aggregated volume
- Price
1,538,990
46,169.70
e)
Date of the transaction
1 August 2017
f)
Place of the transaction
London Stock Exchange, AIM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Michael McMahon
2
Reason for the notification
a)
Position/status
Non-Executive Director, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3p
166,666
d)
Aggregated information
- Aggregated volume
- Price
166,666
4,999.98
e)
Date of the transaction
1 August 2017
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNSThe company news service from the London Stock ExchangeENDMSCPBMRTMBMMMFR
Recent news on Surgical Innovations
See all newsREG - Surgical Innovations - Holding(s) in Company
AnnouncementREG - Surgical Innovations - Holding(s) in Company
AnnouncementREG - Surgical Innovations - Final Results
AnnouncementREG - Surgical Innovations - New exclusive UK distribution agreements secured
AnnouncementREG - Surgical Innovations - Directorate Change & Notice of Results
Announcement